AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 8th, 2023 • Cullinan Oncology, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 to Employment Agreement (the “Amendment”) is made between Cullinan Oncology, Inc., a Delaware corporation (the “Company”), and Nadim Ahmed (the “Executive”) and is effective as of May 1, 2023 (the “Effective Date”). Reference is made to that certain Employment Agreement, by and between the Company and the Executive, effective as of October 18, 2021 (the “Employment Agreement”). All capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Employment Agreement.
